Table S4.
H1299 cells treated with 3 μM AZA (48 hours)
| ||
---|---|---|
Biogroup name | Direction | P value |
Transcription | up | 1.90E-25 |
Cell cycle | down | 7.60E-25 |
Mitosis | down | 8.00E-24 |
Cell division | down | 1.00E-22 |
Cytoskeleton | down | 5.60E-14 |
Microtubule | down | 1.30E-13 |
Spindle | down | 1.80E-13 |
Mitochondrion | down | 1.80E-12 |
Sterol metabolic process | down | 1.40E-11 |
Chromosome | down | 1.20E-10 |
Alcohol metabolic process | down | 2.20E-10 |
Ligase activity | up | 2.40E-10 |
Lipid biosynthetic process | down | 2.70E-10 |
Steroid biosynthetic process | down | 3.00E-10 |
Mitotic sister chromatid segregation | down | 1.90E-09 |
Steroid metabolic process | down | 2.50E-09 |
Sister chromatid segregation | down | 2.90E-09 |
Endoplasmic reticulum | down | 3.60E-09 |
Envelope | down | 4.70E-09 |
Lipid metabolic process | down | 2.60E-08 |
Response to nutrient | down | 7.00E-08 |
Collagen binding | down | 1.60E-07 |
Centrosome | down | 1.70E-07 |
Wound healing | down | 1.90E-07 |
Response to nutrient levels | down | 2.00E-07 |
Intramolecular oxidoreductase activity | down | 2.50E-07 |
Response to extracellular stimulus | down | 2.70E-07 |
Mitochondrial membrane | down | 2.80E-07 |
Microtubule organizing center | down | 2.80E-07 |
Acid–amino acid ligase activity | up | 3.10E-07 |
Cell proliferation | down | 3.60E-07 |
Blood coagulation | down | 3.70E-07 |
Establishment of chromosome localization | down | 4.40E-07 |
Coagulation | down | 4.90E-07 |
Chromosome segregation | down | 5.00E-07 |
Nitrogen compound catabolic process | down | 5.20E-07 |
Kinase binding | up | 5.30E-07 |
Beta-catenin binding | down | 5.50E-07 |
Nucleoplasm | up | 6.10E-07 |
Enzyme inhibitor activity | down | 8.80E-07 |
Alcohol catabolic process | down | 9.80E-07 |
Hemostasis | down | 1.10E-06 |
Transcription cofactor activity | up | 1.10E-06 |
Transcription repressor activity | up | 1.20E-06 |
Midbody | down | 1.30E-06 |
Ligase activity, forming carbon-nitrogen bonds | up | 1.70E-06 |
Establishment of organelle localization | down | 2.00E-06 |
Germ-line sex determination | down | 2.00E-06 |
Oligosaccharyl transferase complex | down | 2.10E-06 |
Response to external stimulus | down | 2.20E-06 |
Oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor | down | 2.20E-06 |
Amine catabolic process | down | 2.20E-06 |
Cytoskeleton organization and biogenesis | down | 2.20E-06 |
Cofactor binding | down | 2.30E-06 |
Coenzyme binding | down | 2.70E-06 |
Transcription corepressor activity | up | 3.00E-06 |
Cell differentiation | up | 3.20E-06 |
mRNA binding | down | 3.30E-06 |
Meiotic chromosome segregation | down | 3.60E-06 |
Homologous chromosome segregation | down | 3.60E-06 |
Nuclear envelope-endoplasmic reticulum network | down | 3.90E-06 |
Oxidoreductase activity, acting on the CH–CH group of donors, NAD or NADP as acceptor | down | 5.00E-06 |
Intramolecular oxidoreductase activity, transposing C=C bonds | down | 5.30E-06 |
Mitotic chromosome condensation | down | 5.50E-06 |
Endoplasmic reticulum part | down | 5.50E-06 |
Transcription factor binding | up | 5.60E-06 |
Organic acid transport | up | 5.70E-06 |
Carboxylic acid transport | up | 5.70E-06 |
Acyl-CoA binding | down | 5.70E-06 |
DNA-directed RNA polymerase II, holoenzyme | up | 5.80E-06 |
Interphase of mitotic cell cycle | down | 6.00E-06 |
Primary sex determination | down | 6.00E-06 |
Cell-matrix adhesion | down | 6.20E-06 |
Hormone activity | down | 6.30E-06 |
Organic acid transmembrane transporter activity | up | 6.30E-06 |
Mitochondrial inner membrane | down | 7.30E-06 |
Cell-substrate adhesion | down | 7.60E-06 |
Transcription activator activity | up | 7.70E-06 |
Mitotic spindle organization and biogenesis | down | 7.90E-06 |
Lyase activity | down | 8.10E-06 |
Sterol transport | down | 8.70E-06 |
Arginine metabolic process | down | 8.70E-06 |
Chromatin assembly | down | 1.00E-05 |
Nitrogen compound biosynthetic process | down | 1.10E-05 |
RNA polymerase II transcription factor activity | up | 1.10E-05 |
Transaminase activity | up | 1.20E-05 |
Meiotic spindle organization and biogenesis | down | 1.30E-05 |
Organelle localization | down | 1.40E-05 |
Isomerase activity | down | 1.40E-05 |
Interphase | down | 1.40E-05 |
Urea cycle intermediate metabolic process | down | 1.50E-05 |
Fatty acid biosynthetic process | down | 1.70E-05 |
Receptor binding | down | 1.70E-05 |
Regulation of body fluids | down | 1.80E-05 |
Condensin complex | down | 1.80E-05 |
Regulation of coagulation | down | 1.90E-05 |
Nuclear envelope | down | 2.20E-05 |
Caveola | down | 2.30E-05 |
Organic acid biosynthetic process | down | 2.30E-05 |
Meiotic cell cycle | down | 2.30E-05 |
Amino acid transport | up | 2.50E-05 |
NADP binding | down | 2.80E-05 |
Protein dimerization activity | up | 2.90E-05 |
Spindle pole | down | 3.40E-05 |
Ubiquitin–protein ligase activity | up | 3.50E-05 |
Transferase activity, transferring nitrogenous groups | up | 3.60E-05 |
Nucleoside metabolic process | down | 3.80E-05 |
Structural constituent of cytoskeleton | down | 3.90E-05 |
Carbohydrate catabolic process | down | 4.10E-05 |
Endoplasmic reticulum membrane | down | 4.30E-05 |
Nucleosome | down | 4.40E-05 |
Nucleotide catabolic process | down | 4.60E-05 |
Cellular chemical homeostasis | down | 4.70E-05 |
Cellular ion homeostasis | down | 4.70E-05 |
Cytokinesis | down | 4.90E-05 |
Muscle cell differentiation | up | 5.00E-05 |
Myeloid cell differentiation | up | 5.20E-05 |
Catabolic process | down | 5.20E-05 |
Oxygen and reactive oxygen species metabolic process | down | 5.20E-05 |
Chromatin | down | 5.30E-05 |
Epidermis development | down | 5.40E-05 |
Oxidoreductase activity, acting on the CH–NH group of donors | down | 5.60E-05 |
SNARE complex | up | 5.60E-05 |
Ligase activity, forming carbon–oxygen bonds | up | 5.70E-05 |
Ligase activity, forming aminoacyl–tRNA and related compounds | up | 5.70E-05 |
Soluble fraction | up | 5.80E-05 |
Endopeptidase inhibitor activity | down | 5.90E-05 |
Protease inhibitor activity | down | 5.90E-05 |
Small protein conjugating enzyme activity | up | 6.00E-05 |
AP-type membrane coat adaptor complex | down | 6.40E-05 |
Cell–cell signaling | down | 6.70E-05 |
Amine transport | up | 6.80E-05 |
Response to DNA damage stimulus | up | 7.20E-05 |
Male sex determination | down | 7.20E-05 |
Cell–cell adhesion | down | 8.00E-05 |
Protein heterodimerization activity | down | 8.00E-05 |
Enzyme binding | up | 8.40E-05 |
Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | down | 9.10E-05 |
Ectoderm development | down | 9.40E-05 |
Positive regulation of progression through cell cycle | down | 0.0001 |
One-carbon compound metabolic process | down | 0.0001 |
Heterogeneous nuclear ribonucleoprotein complex | down | 0.0001 |
Response to stress | down | 0.0001 |
Response to endogenous stimulus | up | 0.0001 |
Cell death | up | 0.0001 |
Death | up | 0.0001 |
Meiosis | down | 0.0001 |
Dioxygenase activity | up | 0.0001 |
Oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen | up | 0.0001 |
Isoprenoid biosynthetic process | down | 0.0001 |
Carbon–carbon lyase activity | down | 0.0001 |
Lipid digestion | down | 0.0001 |
Nitric oxide metabolic process | down | 0.0001 |
Nitric oxide biosynthetic process | down | 0.0001 |
Cellular homeostasis | down | 0.0001 |
Positive regulation of locomotion | down | 0.0001 |
Positive regulation of cell motility | down | 0.0001 |
Sulfur compound biosynthetic process | up | 0.0001 |
Proton-transporting ATP synthase complex, catalytic core F(1) | down | 0.0001 |
Mitochondrial proton-transporting ATP synthase complex | down | 0.0002 |
Muscle development | up | 0.0002 |
Integrator complex | up | 0.0002 |
Caspase inhibitor activity | down | 0.0002 |
Fatty acid binding | down | 0.0002 |
Isoprenoid metabolic process | down | 0.0002 |
Blood vessel morphogenesis | up | 0.0002 |
Vasculogenesis | up | 0.0002 |
Kinetochore | down | 0.0002 |
Low-density lipoprotein binding | down | 0.0002 |
Cell structure disassembly during apoptosis | up | 0.0002 |
Endoplasmic reticulum lumen | down | 0.0002 |
Negative regulation of multicellular organismal process | down | 0.0002 |
Intestinal absorption | down | 0.0002 |
Organelle outer membrane | down | 0.0002 |
Proton-transporting two-sector ATPase complex, catalytic domain | down | 0.0002 |
Regulation of transforming growth factor beta receptor signaling pathway | down | 0.0002 |
Clathrin adaptor complex | down | 0.0002 |
Fatty acid metabolic process | down | 0.0003 |
Replication fork | down | 0.0003 |
Lipoprotein binding | down | 0.0003 |
Insemination | up | 0.0003 |
Behavior | down | 0.0003 |
Leukocyte differentiation | up | 0.0003 |
Single-stranded RNA binding | down | 0.0003 |
Histone acetyltransferase complex | up | 0.0003 |
Oxidoreductase activity, acting on single donors with incorporation of molecular oxygen | up | 0.0003 |
Hemopoiesis | up | 0.0003 |
Outer kinetochore of condensed | down | 0.0003 |
chromosome | ||
Response to virus | up | 0.0003 |
Vasculature development | up | 0.0003 |
DNA-directed RNA polymerase complex | up | 0.0003 |
Perinuclear region of cytoplasm | down | 0.0003 |
Sterol binding | down | 0.0003 |
Generation of precursor metabolites and energy | down | 0.0003 |
Copulation | up | 0.0004 |
Spindle localization | down | 0.0004 |
Establishment of mitotic spindle localization | down | 0.0004 |
Establishment of spindle localization | down | 0.0004 |
Neural crest cell development | down | 0.0004 |
GTPase inhibitor activity | down | 0.0004 |
Notes: Functional groupings of the modulated genes were determined using Gene Ontology classifications in NextBio. The top 200 biogroups most significantly regulated by AZA (at 3 µM) are shown.